Side effects of Covishield vaccine among frontline healthcare workers of a tertiary health care center

Author:

Dhungana DurgaORCID,Regmi Yukta Narayan,Shrestha DeependraORCID,Thapa Krishna,Pun Chandra Bahadur,Upadhayaya Tirthalal,Hirachan Gopi

Abstract

AbstractObjectivesCOVID disease started in the late 2019 and within a short time became a pandemic disease. With the increasing morbidity and mortality all over the world and the therapeutics not doing wonders, scientists were in the attempt to develop vaccines as a mitigating measure. With continuous efforts and developments, different vaccines were developed and rolled out gradually in different countries. Concerns were notable for occurrence of side effects. Hence this study was done to assess the side effects following Covishield vaccination in Nepal at the initial stage.MethodsThis was a cross-sectional study done via snowball sampling method among healthcare workers at a tertiary medical college hospital in Pokhara, Nepal after obtaining ethical consent from the institutional review committee of the concerned hospital. The proforma was sent via online means through different social media platforms and also printed forms were also given to the respondents. A total of 139 respondents were obtained after removing duplications. The data were entered into SPSS and analyzed using descriptive and inferential statistics. P-value ≤ 0.05 was considered statistically significant.ResultsMajority (64.7%) were female healthcare workers. More than half (52.3%) used pre-medication in an attempt to avoid the side effects of vaccine. Most (90.6%) reported at least one side effect-local or systemic to the first dose and approximately three-quarter (74.3%) reported side effect to the second dose. Common side effects were pain at injection site, muscle pain, headache, fatigue and weakness. Most of the side effects were higher with the first dose as compared to the second dose.ConclusionSide effects are common with Covishield vaccination, significantly more with the first dose as compared to the second dose. Female gender, younger age and past covid infection were associated with slightly more occurrence of side effects; however were not found to be statistically significant.

Publisher

Cold Spring Harbor Laboratory

Reference22 articles.

1. Organization WH. Coronavirus disease (COVID-19): Vaccines. 2021.Available from:

2. Ministry of Health and Population N. Situation Updates Covid-19 Dashboard. 2021. Available from: https://covid19.mohp.gov.np/covid/englishSituationReport/628a0e070e598_SitRep833_COVID-19_22-05-2022_EN.pdf

3. BBC. Covid-19 vaccine: First person receives Pfizer jab in UK. BBC. 2020 8 December 2020. Available from: https://www.bbc.com/news/uk-55227325

4. Poudel A. Nepal begins first phase of Covid-19 vaccination drive. The Kathmandu Post. 2021. Available from: https://kathmandupost.com/health/2021/01/27/nepal-begins-first-phase-of-vaccination-drive-against-covid-19

5. ANI. Nepal to administer second dose of Covid-19 vaccine from April 20. Business Standard. 2021 March 7, 202. Available from: https://www.business-standard.com/article/current-affairs/nepal-to-administer-second-dose-of-covid-19-vaccine-from-april-20-121030700027_1.html

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3